Copyright Reports & Markets. All rights reserved.

Insulin Pumps and Accessories Global Market - Forecast to 2026

Request for Sample of this report
Buy now

1 EXECUTIVE SUMMARY 18

    2 INTRODUCTION 23

    • 2.1 KEY TAKEAWAYS 23
    • 2.2 SCOPE OF THE REPORT 23
    • 2.3 REPORT DESCRIPTION 24
    • 2.4 MARKETS COVERED 26
    • 2.5 STAKEHOLDERS 27
    • 2.6 RESEARCH METHODOLOGY 27
      • 2.6.1 MARKET SIZE ESTIMATION 28
      • 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 31
      • 2.6.3 SECONDARY SOURCES 32
      • 2.6.4 PRIMARY SOURCES 32
      • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 33
      • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 34
      • 2.6.7 ASSUMPTIONS 34

    3 MARKET ANALYSIS 36

    • 3.1 INTRODUCTION 36
    • 3.2 MARKET SEGMENTATION 37
    • 3.3 FACTORS INFLUENCING MARKET 38
      • 3.3.1 DRIVERS AND OPPORTUNITIES 39
        • 3.3.1.1 The global rise in the prevalence and incidence of diabetes 39
        • 3.3.1.2 Increase in the use of insulin pumps in-home care settings and disadvantages

      of conventional methods over insulin pumps. 40

      • 3.3.1.3 Increasing distribution agreements, partnerships and collaboration activities 41
      • 3.3.1.4 Increase in product approvals 42
    • 3.3.2 RESTRAINS AND THREATS 42
      • 3.3.2.1 High cost of the continuous subcutaneous insulin infusion therapy(csii) 42
      • 3.3.2.2 Inadequate reimbursement 43
      • 3.3.2.3 Increased product recalls 44
      • 3.3.2.4 Privacy concern and safety issues associated with insulin pumps 44
      • 3.3.2.5 Stringent regulatory requirements for new products 45
  • 3.4 REGULATORY AFFAIRS 47
    • 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 47
      • 3.4.1.1 ISO:9001: 2015 quality management system 47
      • 3.4.1.2 ISO:13485 medical devices 47
    • 3.4.2 U.S. 48
    • 3.4.3 CANADA 49
    • 3.4.4 EUROPE 50
    • 3.4.5 INDIA 50
    • 3.4.6 CHINA 52
    • 3.4.7 JAPAN 53
  • 3.5 CLINICAL TRIALS 54
  • 3.6 PRODUCT RECALLS 57
  • 3.7 PORTER’S FIVE FORCE ANALYSIS 58
    • 3.7.1 THREAT OF NEW ENTRANTS 59
    • 3.7.2 THREAT OF SUBSTITUTES 60
    • 3.7.3 RIVALRY AMONG EXISTING COMPETITORS 60
    • 3.7.4 BARGAINING POWER OF SUPPLIERS 61
    • 3.7.5 BARGAINING POWER OF BUYERS 61
  • 3.8 SUPPLY CHAIN ANALYSIS 62
  • 3.9 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 65
    • 3.9.1 INSULIN PUMPS AND ACCESSORIES MARKET SHARE ANALYSIS 65
  • 3.10 NUMBER OF UNITS SOLD 67
  • 3.11 MARKET PENETRATION 69

    • 4 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY PRODUCTS 72

    • 4.1 INTRODUCTION 72
    • 4.2 INSULIN PUMPS 75
      • 4.2.1 TETHERED INSULIN PUMP 79
      • 4.2.2 PATCH INSULIN PUMP 81
    • 4.3 CONSUMABLES 84

    5 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY APPLICATION 87

    • 5.1 INTRODUCTION 87
    • 5.2 TYPE 1 DIABETES 89
    • 5.3 TYPE 2 DIABETES 92

    6 INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY END-USER 95

    • 6.1 INTRODUCTION 95
    • 6.2 HOSPITALS 97
    • 6.3 AMBULATORY SURGICAL CENTERS 99
    • 6.4 HOME HEALTHCARE 100
    • 6.5 OTHERS 103

    7 INSULIN PUMPS AND ACCESSORIES MARKET BY REGION 105

    • 7.1 INTRODUCTION 105
    • 7.2 NORTH AMERICA 108
      • 7.2.1 U.S. 121
      • 7.2.2 REST OF NORTH AMERICA 125
    • 7.3 EUROPE 129
      • 7.3.1 GERMANY 142
      • 7.3.2 FRANCE 145
      • 7.3.3 U.K. 148
      • 7.3.4 REST OF EUROPE 151
    • 7.4 APAC 154
      • 7.4.1 JAPAN 167
      • 7.4.2 CHINA 171
      • 7.4.3 INDIA 174
      • 7.4.4 REST OF APAC 177
    • 7.5 REST OF THE WORLD 181
      • 7.5.1 BRAZIL 194
      • 7.5.2 REST OF LATIN AMERICA 197
      • 7.5.3 MIDDLE EAST AND OTHERS 201

    8 COMPETITIVE LANDSCAPE 205

    • 8.1 INTRODUCTION 205
    • 8.2 APPROVAL 206
    • 8.3 AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS 209
    • 8.4 NEW PRODUCT LAUNCH 212
    • 8.5 OTHERS 214

    9 MAJOR COMPANIES 217

    • 9.1 DEBIOTECH S.A. 217
      • 9.1.1 OVERVIEW 217
      • 9.1.2 FINANCIALS 218
      • 9.1.3 PRODUCT PORTFOLIO 218
      • 9.1.4 KEY DEVELOPMENTS 218
      • 9.1.5 BUSINESS STRATEGY 218
      • 9.1.6 SWOT ANALYSIS 219
    • 9.2 DIABELOOP S.A. 220
      • 9.2.1 OVERVIEW 220
      • 9.2.2 FINANCIALS 221
      • 9.2.3 PRODUCT PORTFOLIO 221
      • 9.2.4 KEY DEVELOPMENTS 221
      • 9.2.5 BUSINESS STRATEGY 222
      • 9.2.6 SWOT ANALYSIS 223
    • 9.3 F. HOFFMANN-LA ROCHE AG. 224
      • 9.3.1 OVERVIEW 224
      • 9.3.2 FINANCIALS 225
      • 9.3.3 PRODUCT PORTFOLIO 230
      • 9.3.4 KEY DEVELOPMENTS 230
      • 9.3.5 BUSINESS STRATEGY 230
      • 9.3.6 SWOT ANALYSIS 231
    • 9.4 INSULET CORPORATION 232
      • 9.4.1 OVERVIEW 232
      • 9.4.2 FINANCIALS 233
      • 9.4.3 PRODUCT PORTFOLIO 235
      • 9.4.4 KEY DEVELOPMENTS 235
      • 9.4.5 BUSINESS STRATEGY 237
      • 9.4.6 SWOT ANALYSIS 238
    • 9.5 MEDTRONIC PLC 239
      • 9.5.1 OVERVIEW 239
      • 9.5.2 FINANCIALS 240
      • 9.5.3 PRODUCT PORTFOLIO 242
      • 9.5.4 KEY DEVELOPMENTS 243
      • 9.5.5 BUSINESS STRATEGY 244
      • 9.5.6 SWOT ANALYSIS 245
    • 9.6 MICROPORT SCIENTIFIC CORPORATION 246
      • 9.6.1 OVERVIEW 246
      • 9.6.2 FINANCIALS 247
      • 9.6.3 PRODUCT PORTFOLIO 249
      • 9.6.4 KEY DEVELOPMENTS 250
      • 9.6.5 BUSINESS STRATEGY 250
      • 9.6.6 SWOT ANALYSIS 251
    • 9.7 SOOIL DEVELOPMENT CO. LTD. 252
      • 9.7.1 OVERVIEW 252
      • 9.7.2 FINANCIALS 253
      • 9.7.3 PRODUCT PORTFOLIO 253
      • 9.7.4 KEY DEVELOPMENTS 253
      • 9.7.5 BUSINESS STRATEGY 253
      • 9.7.6 SWOT ANALYSIS 254
    • 9.8 TANDEM DIABETES CARE INC. 255
      • 9.8.1 OVERVIEW 255
      • 9.8.2 FINANCIALS 256
      • 9.8.3 PRODUCT PORTFOLIO 259
      • 9.8.4 KEY DEVELOPMENTS 259
      • 9.8.5 BUSINESS STRATEGY 262
      • 9.8.6 SWOT ANALYSIS 263
    • 9.9 VALERITAS HOLDINGS INC. 264
      • 9.9.1 OVERVIEW 264
      • 9.9.2 FINANCIALS 265
      • 9.9.3 PRODUCT PORTFOLIO 265
      • 9.9.4 KEY DEVELOPMENTS 265
      • 9.9.5 BUSINESS STRATEGY 267
      • 9.9.6 SWOT ANALYSIS 268
    • 9.10 YPSOMED HOLDING AG. 269
      • 9.10.1 OVERVIEW 269
      • 9.10.2 FINANCIALS 270
      • 9.10.3 PRODUCT PORTFOLIO 273
      • 9.10.4 KEY DEVELOPMENTS 273
      • 9.10.5 BUSINESS STRATEGY 274

    Insulin pumps and accessories are class of medical devices used for administering insulin in a controlled, precise and automated manner. These devices used in the treatment of diabetes mellitus know as continuous subcutaneous insulin infusion, these insulin systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to death of a patient.
    Insulin pumps & accessories market is segmented on the basis of products, applications, end-users and geography. The insulin pumps & accessories products market is segmented into insulin pumps, consumables, among them insulin pumps held the largest share of the market with XX% in 2019 and are expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps. The tethered insulin pump accounted for the largest share of XX% in 2019 and is expected to grow at a mid single digit CAGR of XX% from 2019 to 2026. Applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026. End-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026.
    Geographically, North America is the largest market, with a share of XX% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a high single digit CAGR of XX% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the insulin pumps & accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
    The insulin pumps & accessories market is expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Increase in the prevalence of diabetes, technological advancements, adoption of insulin pumps over traditional methods and advantages of insulin pumps over the injections and pens are the factors driving the market growth. The increasing trend for wireless insulin pumps, emergence of smart pumps and market expansion in emerging nations and product approvals are expected to offer potential opportunities.
    However, various factors like, high cost, patient safety risks and medication errors associated with insulin pumps, lack of cyber-security in wireless insulin pumps limit the growth of insulin pumps & accessories global market.
    The insulin pumps & accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in insulin pumps & accessories market include F. Hoffmann-La Roche AG (Switzerland), Insulet Corporation (U.S.), Medtronic PLC (Ireland), Tandem Diabetes Care Inc. (U.S.), Valeritas Holdings Inc. (U.S.) and Ypsomed Holdings AG (Switzerland).
    The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
    • North America
    o U.S.
    o Rest of North America
    • Europe
    o Germany
    o France
    o U.K.
    o Rest of Europe
    • Asia-Pacific
    o Japan
    o China
    o India
    o Rest of APAC
    • Rest of the World (RoW)
    o Brazil
    o Rest of Latin America
    o Middle East and Others

    Buy now